| Study,Year | Device Category | Group | N | Mean Procedure Time in Minutes (SD) | Stenting n/N (%) | Direct Stenting n/N (%) | Procedural GP2B3Ai Use n/N (%) | Anti-platelet Drugs Used | Anti-thrombotic Drugs Used |
|---|---|---|---|---|---|---|---|---|---|
| Wita, 2009 | Catheter Aspiration | Diver CE | 19 | 39.5 (10.1) | 19/19 (100) | --- | 19/19 (100) | Aspirin and clopidogrel load pre-PCI | Heparin (ACT >200 s) |
| Control | 23 | 32.3 (18.6) | 23/23 (100) | --- | 23/23 (100) | ||||
| Ozaki, 2006 | Catheter Aspiration | Rescue or Thrombuster systems | 25 | --- | 25/25 (100) | --- | --- | Aspirin 162 mg and ticlopidine 200 mg pre-PCI and post-PCI | Heparin 10,000 U intra-arterial pre-PCI and 20,000 U/d IV post-PCI |
| Distal Balloon Embolic Protection | PercuSurge GuardWire | 24 | --- | 24/24 (100) | --- | --- | |||
| Control | 28 | --- | 28/28 (100) | --- | --- | ||||
Abbreviations: ACT=activated clotting time; d=days; GP2B3Ai=glycoprotein IIbIIIa inhibitor; IV=intravenous; mg=milligram; n=number; N=number of participants in the group; PCI=percutaneous coronary intervention; s=seconds; SD=standard deviation; U=units
From: Appendix E, Baseline and Procedural Characteristics of Included Trials and Studies
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.